PHS Welcomes Dr. Bing Lu, MD, DrPH

Dr. Bing Lu

Dr. Lu is a new professor with tenure who was recruited from the Department of Medicine of Brigham and Women’s Hospital and Harvard Medical School where he served as the director of biostatistics for the Section of Clinical Sciences, and an associate professor of medicine at Harvard. He also previously worked at Brown University. His research expertise is design and analysis of clinical trials and observational studies, epidemiology and outcomes research in chronic diseases including rheumatic diseases, osteoarthritis, and cardiovascular diseases. He brings with him two active NIH RO1 grants.

Dr. Lu is a Professor in Biostatistics and Epidemiology. He has a multidisciplinary background in biostatistics, epidemiology, and medicine, with specific teaching and research interests in longitudinal analysis, design and analysis of clinical trials, statistical methods in epidemiology, and outcomes research of chronic diseases. As the PI, Co-I and lead biostatistician, Dr. Lu has been involved in numerous established and innovative projects in a variety of areas including rheumatoid arthritis, osteoarthritis, cardiovascular disease, lupus, obesity, and women’s health. He has extensive experience in studies using large epidemiological data including the Nurses’ Health Study (NHS), Osteoarthritis Initiative (OAI), Women’s Health Initiative (WHI), and National Health and Nutrition Examination Survey (NHANES).

Dr. Lu is an elected fellow of the American College of Epidemiology. He has served as an Associate Editor for Contemporary Clinical Trials, an international journal of clinical trial methodology, and Associate Editor for Arthritis & Rheumatology, a prestigious journal of the American College of Rheumatology. Dr. Lu’s statistical interests include design and analysis of clinical trials & observational studies, statistical methods in epidemiology, longitudinal data analysis, and causal inference.